These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34509407)

  • 1. Recognition and Implications of Undiagnosed Cardiac Amyloid Patients in HFpEF Trials.
    Cheng RK; Maurer MS
    JACC Heart Fail; 2021 Nov; 9(11):803-806. PubMed ID: 34509407
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac transthyretin/leukocyte chemotactic factor (LECT) 2 double amyloidosis in a patient suffering from heart failure.
    Greulich S; Mahrholdt H; Casadonte R; Steinmüller-Magin L; Latus J; Blessing F; Kriegsmann J; Bekeredjian R; Gawaz M; Klingel K
    Clin Res Cardiol; 2023 Mar; 112(3):444-449. PubMed ID: 35925392
    [No Abstract]   [Full Text] [Related]  

  • 3. Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
    Culotta V; Moon JC
    Rev Esp Cardiol (Engl Ed); 2016 Oct; 69(10):888-889. PubMed ID: 27514622
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyloid transthyretin cardiac amyloidosis with different manifestations, test findings and types.
    Budweg J; Al-Ani M; Assaf Y; Parker A; Aranda J
    BMJ Case Rep; 2023 Apr; 16(4):. PubMed ID: 37080632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
    Chen W; Ton VK; Dilsizian V
    Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transthyretin Amyloidosis: A "Zebra" of Many Stripes.
    Semigran MJ
    J Am Coll Cardiol; 2016 Jul; 68(2):173-5. PubMed ID: 27386770
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial Commentary: Advances in transthyretin amyloid cardiomyopathy.
    Benson MD; Dasgupta NR
    Trends Cardiovasc Med; 2021 Jan; 31(1):67-68. PubMed ID: 31948855
    [No Abstract]   [Full Text] [Related]  

  • 8. "SGLT2i in patients with transthyretin cardiac amyloidosis, a well-tolerated option for heart failure treatment? Results from a small, real-world, patients series" comment.
    Patoulias D; Papadopoulos C; Doumas M
    Intern Emerg Med; 2022 Aug; 17(5):1553-1554. PubMed ID: 35334061
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis.
    Goldstein DS
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1442-1445. PubMed ID: 27838301
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions.
    Khedraki R
    Curr Opin Cardiol; 2022 May; 37(3):272-284. PubMed ID: 35612939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation.
    Khan MS; Sperry BW; Butler J
    Eur J Heart Fail; 2024 Jan; 26(1):74-76. PubMed ID: 38191996
    [No Abstract]   [Full Text] [Related]  

  • 12. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.
    Mohammed SF; Mirzoyev SA; Edwards WD; Dogan A; Grogan DR; Dunlay SM; Roger VL; Gertz MA; Dispenzieri A; Zeldenrust SR; Redfield MM
    JACC Heart Fail; 2014 Apr; 2(2):113-22. PubMed ID: 24720917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
    Sperry BW; Jones BM; Vranian MN; Hanna M; Jaber WA
    JACC Cardiovasc Imaging; 2016 Jul; 9(7):904-906. PubMed ID: 27085437
    [No Abstract]   [Full Text] [Related]  

  • 14. [Transthyretin amyloid cardiomyopathy].
    Hansen PR; Krakauer M
    Ugeskr Laeger; 2020 Feb; 182(6):. PubMed ID: 32089152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin amyloid cardiomyopathy.
    Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
    Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable.
    Rubin J; Maurer MS
    Annu Rev Med; 2020 Jan; 71():203-219. PubMed ID: 31986086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of cardiac transthyretin amyloidosis: an update.
    Emdin M; Aimo A; Rapezzi C; Fontana M; Perfetto F; Seferović PM; Barison A; Castiglione V; Vergaro G; Giannoni A; Passino C; Merlini G
    Eur Heart J; 2019 Dec; 40(45):3699-3706. PubMed ID: 31111153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant Thr95Ile Transthyretin-Related Cardiac Amyloidosis With Polyneuropathy.
    Kim K; Oh J; Lee ST; Shim HS; Kang SM
    Circ J; 2019 Oct; 83(11):2328. PubMed ID: 31243187
    [No Abstract]   [Full Text] [Related]  

  • 20. Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
    Lohrmann G; Pipilas A; Mussinelli R; Gopal DM; Berk JL; Connors LH; Vellanki N; Hellawell J; Siddiqi OK; Fox J; Maurer MS; Ruberg FL
    J Card Fail; 2020 Sep; 26(9):753-759. PubMed ID: 31805416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.